Background Incurable cancer, which often constitutes an enormous challenge for patients,
their families, and medical professionals, profoundly affects the patient's physical and …

Background Health‐related quality of life (HRQoL) has been shown to be a prognostic factor
for cancer survival in randomized clinical trials and observational “real‐world” cohort …

Chronotherapeutics aim at treating illnesses according to the endogenous biologic rhythms,
which moderate xenobiotic metabolism and cellular drug response. The molecular clocks …

Abstract Purpose Symptomatic adverse events (AEs) are monitored by clinicians as part of
all US-based clinical trials in cancer via the US National Cancer Institute's Common …

Abstract Background Long noncoding RNAs (lncRNAs) play crucial roles in tumor
progression and are aberrantly expressed in various cancers. However, the functional roles …

Background Cancer survivors experience numerous disease and treatment‐related adverse
outcomes and poorer health‐related quality of life (HRQoL). Exercise interventions are …

Background People with cancer undergoing active treatment experience numerous disease‐
and treatment‐related adverse outcomes and poorer health‐related quality of life (HRQoL) …

BACKGROUND: Cancer patients and oncologists believe that psychological variables
influence the course of cancer, but the evidence remains inconclusive. This meta‐analysis …

Purpose To compare the quality of life (QoL) of patients receiving oxaliplatin, irinotecan,
fluorouracil, and leucovorin (FOLFIRINOX) or gemcitabine as first-line chemotherapy and to …

Although low-grade gliomas (LGG) have a less aggressive course than do high-grade
gliomas, the outcome of these tumours is ultimately fatal in most patients. Both the tumour …